FindTrial
Sign In

A SPLIT SCALP STUDY OF THE EFFECTS OF TWO INJECTABLES, PLATELET RICH PLASMA AND INJECTABLE-PLATELET RICH FIBRIN IN THE TREATMENT OF MALE PATTERN BALDNESS.

PLATELET RICH PLASMA VERSUS INJECTABLE-PLATELET RICH FIBRIN IN THE TREATMENT OF MALE PATTERN BALDNESS. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059182
Enrollment
36
Registered
2023-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: INJECTABLE PLATELET RICH FIBRIN: INJECTABLE PLATELET RICH FIBRIN WILL BE INJECTED ON THE RIGHT SIDE OF THE SCALP WITH INSULIN SYRINGES. Control Intervention1: PLATELET RICH PLASMA: PLAT

Sponsors

Dr SHIVAKUMAR PATIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) MALES WITH ANDROGENETIC ALOPECIA. 2) NORWOOD GRADE 2 TO GRADE 5.

Exclusion criteria

Exclusion criteria: 1) PATIENTS WITH COAGULOPATHY. 2) PATIENTS WITH INFLAMMATORY AND AUTOIMMUNE CONDITIONS OF SCALP LIKE SEBORRHEIC DERMATITIS, SCALP PSORIASIS, ALOPECIA AREATA, CICATRICIAL ALOPECIA.

Design outcomes

Primary

MeasureTime frame
36 is the sample size calculated.Timepoint: 1 year—

Secondary

MeasureTime frame
trichoscopy is used to the determine the effect of the intervention.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr. SHIVAKUMAR PATIL.

Jawaharlal Nehru Medical Collage, KLE University

shivakumarkpatil@gmail.com9844512315

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026